Richard E. Kast

3.9k total citations
121 papers, 2.3k citations indexed

About

Richard E. Kast is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Richard E. Kast has authored 121 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 37 papers in Genetics and 33 papers in Oncology. Recurrent topics in Richard E. Kast's work include Glioma Diagnosis and Treatment (29 papers), Cancer, Stress, Anesthesia, and Immune Response (13 papers) and Cancer, Hypoxia, and Metabolism (10 papers). Richard E. Kast is often cited by papers focused on Glioma Diagnosis and Treatment (29 papers), Cancer, Stress, Anesthesia, and Immune Response (13 papers) and Cancer, Hypoxia, and Metabolism (10 papers). Richard E. Kast collaborates with scholars based in United States, Germany and Italy. Richard E. Kast's co-authors include Marc‐Eric Halatsch, Georg Karpel‐Massler, Eric Lewin Altschuler, Kevin F Foley, Christian Rainer Wirtz, Daniele Focosi, Ricardo Ribeiro‐dos‐Santos, Milena Botelho Pereira Soares, Mike‐Andrew Westhoff and Annika Dwucet and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Richard E. Kast

112 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard E. Kast United States 26 900 454 453 342 274 121 2.3k
Imola Wilhelm Hungary 28 888 1.0× 211 0.5× 511 1.1× 249 0.7× 94 0.3× 72 2.5k
David A. Katz United States 27 1.1k 1.2× 203 0.4× 527 1.2× 192 0.6× 98 0.4× 64 3.4k
Shinya Dohgu Japan 31 1.0k 1.2× 102 0.2× 463 1.0× 192 0.6× 191 0.7× 78 3.7k
Phuong Le United States 34 2.1k 2.3× 180 0.4× 614 1.4× 314 0.9× 81 0.3× 75 4.0k
Jun Wei China 31 1.8k 2.0× 106 0.2× 501 1.1× 248 0.7× 185 0.7× 169 3.6k
Małgorzata Burek Germany 32 1.2k 1.4× 341 0.8× 698 1.5× 375 1.1× 72 0.3× 83 3.3k
Shinsuke Nakagawa Japan 23 845 0.9× 137 0.3× 566 1.2× 169 0.5× 95 0.3× 45 2.9k
Thomas A. White United States 34 1.6k 1.7× 237 0.5× 367 0.8× 272 0.8× 72 0.3× 69 4.9k
Gunnar Cario Germany 31 1.4k 1.5× 284 0.6× 753 1.7× 283 0.8× 46 0.2× 126 4.3k
Min Gong China 26 1.4k 1.6× 313 0.7× 145 0.3× 602 1.8× 59 0.2× 83 2.6k

Countries citing papers authored by Richard E. Kast

Since Specialization
Citations

This map shows the geographic impact of Richard E. Kast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Kast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Kast more than expected).

Fields of papers citing papers by Richard E. Kast

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard E. Kast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Kast. The network helps show where Richard E. Kast may publish in the future.

Co-authorship network of co-authors of Richard E. Kast

This figure shows the co-authorship network connecting the top 25 collaborators of Richard E. Kast. A scholar is included among the top collaborators of Richard E. Kast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard E. Kast. Richard E. Kast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Jong‐Hoon, Consolato Sergi, Richard E. Kast, et al.. (2024). Aggravating mechanisms from COVID-19. Virology Journal. 21(1). 228–228. 3 indexed citations
2.
Kast, Richard E.. (2024). Reducing Brain Edema Using Berotralstat, an Inhibitor of Bradykinin, Repurposed as Treatment Adjunct in Glioblastoma. SHILAP Revista de lepidopterología. 5(3). 223–233.
3.
Lee, Jong‐Hoon, Consolato Sergi, Richard E. Kast, et al.. (2024). Basic implications on three pathways associated with SARS-CoV-2. Biomedical Journal. 48(2). 100766–100766. 3 indexed citations
4.
Kast, Richard E., Michal Hlaváč, Pamela Fischer‐Posovszky, et al.. (2024). Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro. British Journal of Cancer. 130(8). 1365–1376. 8 indexed citations
5.
Kast, Richard E., Alex Alfieri, Hazem Assi, et al.. (2022). MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen. Cancers. 14(10). 2563–2563. 9 indexed citations
6.
Kast, Richard E.. (2021). Adding high-dose celecoxib to increase effectiveness of standard glioblastoma chemoirradiation. Annales Pharmaceutiques Françaises. 79(5). 481–488. 8 indexed citations
7.
Kast, Richard E.. (2018). Inhibiting the NLRP3 Inflammasome With Methylene Blue as Treatment Adjunct in Myelodysplasia. Frontiers in Oncology. 8. 280–280. 9 indexed citations
8.
Kast, Richard E.. (2015). Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectiveness. SpringerPlus. 4(1). 638–638. 16 indexed citations
9.
Kast, Richard E.. (2015). Agomelatine or ramelteon as treatment adjuncts in glioblastoma and other M1- or M2-expressing cancers. Współczesna Onkologia. 2(2). 157–162. 20 indexed citations
10.
Karpel‐Massler, Georg, Mike‐Andrew Westhoff, Shaoxia Zhou, et al.. (2013). Combined Inhibition of HER1/EGFR and RAC1 Results in a Synergistic Antiproliferative Effect on Established and Primary Cultured Human Glioblastoma Cells. Molecular Cancer Therapeutics. 12(9). 1783–1795. 48 indexed citations
11.
Rappa, Francesca, Francesco Cappello, Marc‐Eric Halatsch, Angelika Scheuerle, & Richard E. Kast. (2012). Aldehyde dehydrogenase and HSP90 co-localize in human glioblastoma biopsy cells. Biochimie. 95(4). 782–786. 9 indexed citations
12.
Söderlund, Johan, Sophie Erhardt, & Richard E. Kast. (2010). Acyclovir inhibition of IDO to decrease Tregs as a glioblastoma treatment adjunct. Journal of Neuroinflammation. 7(1). 44–44. 21 indexed citations
13.
Foley, Kevin T., Richard E. Kast, & Eric Lewin Altschuler. (2008). Ritonavir and disulfiram have potential to inhibit caspase-1 mediated inflammation and reduce neurological sequelae after minor blast exposure. Medical Hypotheses. 72(2). 150–152. 5 indexed citations
14.
Kast, Richard E. & Eric Lewin Altschuler. (2008). The earliest example of the hyperactivity subtype of attention deficit hyperactivity disorder (ADHD) in Jan Steen's 'The Village School' (c. 1670).. PubMed. 98(8). 594–5. 2 indexed citations
15.
16.
Kast, Richard E.. (2007). Melanoma inhibition by cyclooxygenase inhibitors. Medical Oncology. 24(1). 1–6. 16 indexed citations
17.
Altschuler, Eric Lewin & Richard E. Kast. (2003). Bupropion for Blau syndrome. Medical Hypotheses. 62(2). 297–298. 3 indexed citations
18.
19.
Kast, Richard E.. (2002). Ribavirin in Cancer Immunotherapies Controlling Nitric Oxide Helps Generate Cytotoxic Lymphocyte. Cancer Biology & Therapy. 1(6). 626–630. 4 indexed citations
20.
Kast, Richard E.. (2001). Borage oil reduction of rheumatoid arthritis activity may be mediated by increased cAMP that suppresses tumor necrosis factor-alpha. International Immunopharmacology. 1(12). 2197–2199. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Imola Wilhelm Breakdown of academic impact, for papers by David A. Katz Breakdown of academic impact, for papers by Shinya Dohgu Breakdown of academic impact, for papers by Phuong Le Breakdown of academic impact, for papers by Jun Wei Breakdown of academic impact, for papers by Małgorzata Burek Breakdown of academic impact, for papers by Shinsuke Nakagawa Breakdown of academic impact, for papers by Thomas A. White Breakdown of academic impact, for papers by Gunnar Cario Breakdown of academic impact, for papers by Min Gong
Rankless by CCL
2026